Introduction: Central nervous system (CNS) penetration-effectiveness (CPE) rank was proposed in 2008 as an estimate of penetration of ARV regimen into the CNS, and validated as predictor of CSF HIV-1 replication. Results on predictive role of CPE on neurocognitive and clinical outcome were conflicting. Material and Methods: Retrospective, cross-sectional analysis of neurocognitive profile in HIV-infected cART-treated patients. All patients underwent neuropsychological (NP) assessment by standardized battery of 14 tests on 5 different domains. People were classified as having NCI if they scored 1 standard deviation (SD) below the normal mean in at least two tests, or 2 SD below in one test. Linear and logistic regression analyses were fitted using as outcome Npz8 and impaired/not impaired respectively. Results: A total of 660 HIV-infected cART-treated individuals from 2009 to 2014, contributing a total of 1003 tests (mean age 49 (IQR 43Á56), male 82%; median current CD4 586/mm 3 ; 18% HCV infected; HIV-RNA B40 cp/mL in 84%). Current ARV regimen was 2NRTIs'1NNRTI 50.3%, 2NRTI'1PI/r in 32.6%, NRTI sparing in 11.1%. Mean CPE of current regimens was 6.6 (95% CI 6.5Á6.7). As per test multivariable analysis, higher CPE values were associated to poor NP tasks (Beta0(0,09; 95% CI (0,14 (0,03; p00.002 at multivariable linear regression). The association between higher CPE and increased NCI risk was confirmed at multivariable logistic regression, with a 1.24-fold risk of NCI occurrence for each point increase of CPE of current regimen at the time of NP testing (see Table 1 ). In a sensitivity analysis performed only on patients at the first NP test, the association between higher CPE and poor NP tasks and enhanced NCI risk was only marginally confirmed (Beta0(0,05; [(0,12Á0,02]; p00,19; OR 1,13 [0,95Á1,34]; p00.17). Older age, longer time from HIV diagnosis, current CD4 count B350 cell/mm 3 and lower education level were all associated to an increased risk of NCI. Conclusions: In our analysis, higher CPE rank is associated to poorly performing at NP tasking. Even if selection bias could not be excluded due to retrospective cross-sectional design, these results fitted with the direct correlation between high CPE and HIV dementia recently recorded in a large observational database. We think that CPE use to guide ART in patients neurocognitively impaired should be revised. 
